<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of pregnancy after resolution of an episode of acute idiopathic preterm labor</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of pregnancy after resolution of an episode of acute idiopathic preterm labor</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Management of pregnancy after resolution of an episode of acute idiopathic preterm labor</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steve Caritis, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Hyagriv N Simhan, MD, MS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Malavika Prabhu, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 04, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The management of pregnancies after resolution of a suspected episode of acute idiopathic preterm labor (PTL) lacks high quality evidence on which to base recommendations. No large randomized trials have compared combinations of management strategies.</p><p>This topic will present our approach to management of patients who do not give birth and do not have advanced cervical dilation after resolution of an acute episode of suspected idiopathic PTL. The evaluation and management of patients with suspected acute PTL are discussed separately. (See  <a class="medical medical_review" href="/d/html/6798.html" rel="external">"Preterm labor: Clinical findings, diagnostic evaluation, and initial treatment"</a> and  <a class="medical medical_review" href="/d/html/6742.html" rel="external">"Inhibition of acute preterm labor"</a>.)</p><p class="headingAnchor" id="H2787995108"><span class="h1">OUR APPROACH</span></p><p class="headingAnchor" id="H1855061878"><span class="h2">Antenatal corticosteroids</span><span class="headingEndMark"> — </span>Pregnancies from 22+0 to 33+6 weeks of gestation predicted to be at increased risk for preterm birth in the next seven days are candidates for an initial course of antenatal corticosteroids to reduce neonatal morbidity and mortality if preterm birth occurs. Administration of an initial course of antenatal corticosteroids at 34+0 to 36+6 weeks of gestation is controversial; however, there is consensus that tocolysis should not be used to delay delivery for completion of a course of steroids at this gestational age. The use of antenatal corticosteroids at various gestational ages and the indications for rescue/salvage/booster therapy in patients who have received an initial course of therapy are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/6796.html" rel="external">"Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery"</a>.)</p><p class="headingAnchor" id="H3964199604"><span class="h2">Continuation of progesterone supplementation</span><span class="headingEndMark"> — </span>For patients who had been receiving supplemental vaginal <a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">progesterone</a> to reduce the risk of preterm birth because of a short cervix on ultrasound examination, we continue their same progesterone dose after resolution of an episode of suspected PTL.</p><p>We would not newly initiate <a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">progesterone</a> supplementation in patients who were not candidates for therapy before their episode of PTL. (See <a class="local">'Initiation of progesterone supplementation'</a> below.)</p><p class="headingAnchor" id="H127127778"><span class="h2">Duration of hospitalization</span><span class="headingEndMark"> — </span>After resolution of an episode of suspected acute PTL with intact membranes, we consider several factors when determining the duration of hospitalization.</p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are ≥34 weeks of gestation with suspected acute PTL generally do not receive tocolytic therapy because 34 weeks defines the threshold at which perinatal morbidity and mortality are too low to justify the potential maternal and fetal complications and costs associated with inhibition of PTL and short-term delay of delivery (see  <a class="medical medical_review" href="/d/html/6742.html" rel="external">"Inhibition of acute preterm labor", section on 'Lower and upper gestational age limits'</a>). However, they may receive a course of antenatal corticosteroid therapy; practice at this gestational age varies and is reviewed separately. (See  <a class="medical medical_review" href="/d/html/6796.html" rel="external">"Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery", section on '34+0 or more weeks'</a>.)</p><p></p><p class="bulletIndent1">These patients can be discharged when the episode of suspected PTL resolves, as long as tests of fetal well-being are reassuring (reactive nonstress test or good biophysical profile score) and no additional complications are present that warrant hospitalization (eg, fever, abruption, preterm prelabor rupture of membranes, pregnancy-related hypertension).</p><p></p><p class="bulletIndent1">For patients with advanced cervical dilation/effacement and/or a history of rapid labor, the travel time to a hospital with appropriate levels of obstetric and neonatal care services needs to be considered. Many of these patients will need to remain in the hospital because of the risk of giving birth in a less than optimal setting if they are discharged.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients &lt;34 weeks of gestation with suspected acute PTL, we base the duration of hospitalization on patient-specific factors, including gestational age, cervical status, past obstetric history, distance between their residence and the hospital, and coexisting obstetric and medical problems [<a href="#rid1">1,2</a>]. Patients who receive antenatal corticosteroids generally remain in the hospital until the course has been completed (eg, 24 hours after the second dose of <a class="drug drug_general" data-topicid="9139" href="/d/drug information/9139.html" rel="external">betamethasone</a>), but this decision can be individualized.</p><p></p><p>The only randomized trial designed to determine whether hospitalization of patients after resolution of an episode of PTL increased the proportion of births ≥36 weeks compared with patients discharged home did not find a benefit [<a href="#rid3">3</a>]. In this trial, 101 participants with singleton gestations, intact membranes, mean cervical dilation 2.7 cm, and a diagnosis of arrested PTL between 24+0 and 33+4 weeks of gestation were randomly assigned to hospitalization until 34+0 weeks or discharged home upon completion of a course of <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a>. Tocolytics were not administered; contractions ceased with conservative management alone (hydration, <a class="drug drug_general" data-topicid="9608" href="/d/drug information/9608.html" rel="external">meperidine</a>). In both groups, approximately 70 percent of participants gave birth at ≥36 weeks of gestation. However, the trial was underpowered, and the findings are not generalizable to the more clinically relevant population of patients with arrested PTL after tocolytic therapy [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H1325241469"><span class="h2">Outpatient follow-up</span><span class="headingEndMark"> — </span>We schedule an office visit or telephone/telemedicine contact one week after discharge from the hospital and usually weekly thereafter for both singleton and twin pregnancies. These visits provide an opportunity to discuss signs and symptoms of PTL and to check for cervical change in the absence of symptoms that may warrant a change in management. For example, a patient whose cervix was 2 cm dilated on hospital discharge at 25 weeks but 4 cm dilated on follow-up at 28 weeks may be a candidate for a rescue course of steroids. (See  <a class="medical medical_review" href="/d/html/6796.html" rel="external">"Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery", section on 'Use of rescue (salvage, booster) ACS'</a>.)</p><p>In patients who remain stable and have a closed, uneffaced cervix, it may be safe to resume the usual frequency of prenatal care visits. No data are available.</p><p class="headingAnchor" id="H2"><span class="h2">Physical activity</span></p><p class="headingAnchor" id="H24606278"><span class="h3">Activities of daily life</span><span class="headingEndMark"> — </span>We advise patients that they may resume most activities of daily living and also advise avoiding daytime bed rest given the lack of evidence of its efficacy for reduction of preterm birth and the known significant thromboembolic and other risks of prolonged immobility [<a href="#rid5">5</a>]. We suggest against lifting anything greater than 20 pounds, based on longstanding practice patterns.</p><p>A trial of 120 with arrested at 24 to 34 weeks with &lt;3 cm, 48 hours of hospitalization, and ≤25 mm found that activity restriction (pelvic rest, prohibition of sexual activity, and reduction of work and/or nonwork activity) did not reduce the risk of preterm birth &lt;37 weeks compared with no activity restriction (25 versus 38 percent; RR 0.65, 95% CI 0.38-1.12) [<a href="#rid6">6</a>]. A systematic review found inadequate evidence either supporting or refuting the use of bed rest at home or in-hospital to prevent preterm birth in singleton gestations at high risk of preterm birth (1 trial, &gt;1200 participants) [<a href="#rid7">7</a>]. Another systematic review found inadequate evidence to support a policy of routine hospitalization for bed rest in multiple gestations (7 trials, &gt;700 participants) [<a href="#rid8">8</a>]. On the other hand, there is clear evidence that bed rest has potential harms: It increases venous thromboembolism risk, promotes loss of trabecular bone density and musculoskeletal deconditioning, and places significant psychosocial strain on individuals and families [<a href="#rid9">9-16</a>].</p><p class="headingAnchor" id="H24606285"><span class="h3">Exercise</span><span class="headingEndMark"> — </span>We agree with the general consensus that pregnant patients at high risk for preterm birth should limit recreational exercise, particularly strength training and heavy lifting (&gt;20 pounds) [<a href="#rid17">17,18</a>]. This is a prudent approach because most trials of recreational exercise in pregnancy have excluded those at increased risk for PTL or those who developed PTL during the trial; therefore, it is difficult to assess the effect of recreational exercise on pregnancy outcome in these individuals. (See  <a class="medical medical_review" href="/d/html/412.html" rel="external">"Exercise during pregnancy and the postpartum period"</a> and  <a class="medical medical_review" href="/d/html/6761.html" rel="external">"Spontaneous preterm birth: Overview of risk factors and prognosis"</a>.)</p><p class="headingAnchor" id="H3971836365"><span class="h3">Work</span><span class="headingEndMark"> — </span>We suggest that patients at high risk for preterm birth avoid returning to work if this involves working more than 40 hours per week, night shifts, prolonged standing (eg, more than a total of 8 hours or more than 4 continuous hours per 24-hour period), and heavy physical work, as this activity level has been variably associated with PTL and preterm birth [<a href="#rid19">19-22</a>]. However, the effect of occupational work on preterm birth is difficult to analyze because occupational activities are complex constructs involving duration of work, shift effects, psychological and physical stress, lifting (frequency and amount of weight), length of time standing, etc, and thus cannot readily be characterized in a simple way. (See  <a class="medical medical_review" href="/d/html/439.html" rel="external">"Working during pregnancy"</a> and  <a class="medical medical_review" href="/d/html/6761.html" rel="external">"Spontaneous preterm birth: Overview of risk factors and prognosis"</a>.)</p><p class="headingAnchor" id="H24606332"><span class="h3">Sexual intercourse</span><span class="headingEndMark"> — </span>We tell patients with an arrested episode of PTL that they should consider avoiding sexual intercourse if they experience an increased frequency or intensity of contractions afterward. There is no strong evidence that sexual activity affects the risk of preterm birth or onset of labor in healthy individuals. However, it is theoretically possible that a small subgroup of susceptible individuals may develop PTL with sexual intercourse because both prostaglandins in semen and orgasm can increase myometrial activity [<a href="#rid23">23-26</a>]. (See  <a class="medical medical_review" href="/d/html/6761.html" rel="external">"Spontaneous preterm birth: Overview of risk factors and prognosis", section on 'Role of coitus'</a>.)</p><p class="headingAnchor" id="H34955464"><span class="h2">Travel</span><span class="headingEndMark"> — </span>It is unlikely that car, train, or even airline travel significantly increases the risk of PTL or preterm birth; however, patients who wish to travel need to consider the risk of pregnancy complications away from their usual source of medical care, as well as the availability of medical resources and their medical insurance coverage at their destination [<a href="#rid27">27-30</a>]. (See  <a class="medical medical_review" href="/d/html/112420.html" rel="external">"Prenatal care: Patient education, health promotion, and safety of commonly used drugs", section on 'Travel'</a>.)</p><p class="headingAnchor" id="H1746987632"><span class="h1">INEFFECTIVE AND UNPROVEN INTERVENTIONS</span></p><p class="headingAnchor" id="H2438089187"><span class="h2">Maintenance tocolysis</span><span class="headingEndMark"> — </span>After acute inhibition of PTL, meta-analyses of randomized trials have consistently found that, compared with placebo/no treatment, maintenance tocolysis with <a class="drug drug_general" data-topicid="9700" href="/d/drug information/9700.html" rel="external">nifedipine</a>, <a class="drug drug_general" data-topicid="9977" href="/d/drug information/9977.html" rel="external">terbutaline</a> (orally or via pump), or <a class="drug drug_general" data-topicid="9585" href="/d/drug information/9585.html" rel="external">magnesium sulfate</a> did not result in statistically significant prolongation of pregnancy, reduction of preterm birth, or improvement in neonatal outcome [<a href="#rid31">31-34</a>]. However, most trials were small and had study design limitations. Tocolytic drugs may have a role in providing symptomatic relief with respect to intensity and frequency of contractions, but the risk of serious adverse events, especially with prolonged terbutaline pump or magnesium sulfate therapy, outweighs any potential benefit [<a href="#rid35">35-37</a>].</p><p>A randomized trial in over 500 patients that compared atosiban (an oxytocin antagonist) with placebo for maintenance therapy after an episode of PTL also found that active therapy did not result in statistically significant reductions in preterm birth before 28, 32, or 37 weeks of gestation, although the time to first recurrence of labor was prolonged (33 days with atosiban versus 28 days with placebo) [<a href="#rid38">38,39</a>].</p><p class="headingAnchor" id="H1762726421"><span class="h2">Antibiotic prophylaxis</span><span class="headingEndMark"> — </span>There is no convincing evidence of benefit from prophylactic antibiotic therapy for patients with PTL with intact membranes and no evidence of infection. In a meta-analysis of randomized trials of asymptomatic, nonlaboring participants at high risk of preterm birth assigned to prophylactic antibiotic therapy or placebo, antibiotic therapy did not result in statistically significant reductions in preterm birth, irrespective of criteria used to assess risk, the antimicrobial agent administered, or the gestational age at the time of treatment [<a href="#rid40">40</a>]. A subsequent meta-analysis of trials of routine antibiotic prophylaxis in different types of pregnant patients (eg, unselected patients, patients at high risk of preterm birth by past histories, patients who were predominantly HIV positive) affirmed these findings [<a href="#rid41">41</a>].</p><p>Although group B <em>Streptococcus</em> (GBS) chemoprophylaxis is recommended for patients with active PTL, it is discontinued once the patient is no longer at imminent risk of preterm birth, even if the GBS rectovaginal culture is positive, as continued therapy is not beneficial. Guidelines for GBS prophylaxis are reviewed separately. (See  <a class="medical medical_review" href="/d/html/438.html" rel="external">"Prevention of early-onset group B streptococcal disease in neonates", section on 'Special populations'</a>.)</p><p class="headingAnchor" id="H2069376010"><span class="h2">Initiation of progesterone supplementation</span><span class="headingEndMark"> — </span>For patients who were not candidates for vaginal <a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">progesterone</a> supplementation before their episode of suspected PTL, we do not begin vaginal progesterone as an adjunct to tocolysis or as part of maintenance therapy after resolution of the episode, regardless of cervical length, because available data suggest that it is not beneficial. </p><p>Randomized trials evaluating various types of <a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">progesterone</a> supplementation in this setting have reported disparate results, likely related to factors such as differences in size, type of progestin, route of administration, and inclusion of a placebo versus a no treatment arm. In a meta-analysis of randomized trials, maintenance progesterone (vaginal, intramuscular, or oral) was not more effective than placebo [<a href="#rid42">42</a>]:   </p><p class="bulletIndent1"><span class="glyph">●</span>Delivery &lt;37 weeks – RR 0.94 (95% CI 0.80-1.10; 11 trials)</p><p class="bulletIndent1"><span class="glyph">●</span>Delivery &lt;34 weeks – RR 0.87 (95% CI 0.66-1.15; 9 trials)</p><p class="bulletIndent1"><span class="glyph">●</span>No statistically significant difference in neonatal sepsis, necrotizing enterocolitis, intraventricular hemorrhage, admission to neonatal intensive care unit (NICU), respiratory distress syndrome, or neonatal death</p><p></p><p class="headingAnchor" id="H2903697011"><span class="h2">Cervical pessary</span><span class="headingEndMark"> — </span>The first clinical trial to evaluate use of a cervical pessary versus routine care in patients with singleton pregnancies and short cervical length after an episode of arrested PTL reported a trend in reduction in spontaneous preterm birth &lt;34 weeks (10.7 versus 13.7 percent with routine care, relative risk [RR] 0.78, 95% CI 0.45-1.38) and statistically significant reductions in spontaneous preterm birth &lt;37 weeks (14.7 versus 25.1 percent, RR 0.58, 95% CI 0.38-0.90) and preterm prelabor rupture of membranes (2.3 versus 8.0 percent, RR 0.28, 95% CI 0.09-0.84); however, neonatal morbidity and mortality were similar in both groups [<a href="#rid43">43</a>]. These results are promising, but the number of spontaneous preterm births in the trial was relatively small (43 &lt;34 weeks, 70 &lt;37 weeks). A subsequent smaller trial, which was halted early for futility, observed no reduction in preterm birth &lt;32, 34, or 37 weeks [<a href="#rid44">44</a>].</p><p>The major side effect of using a pessary is vaginal discharge, which occurs in most patients. No serious side effects have been reported [<a href="#rid45">45,46</a>]. Nevertheless, until a benefit in neonatal outcome is established, we suggest only utilizing pessaries in the context of a clinical trial. (See  <a class="medical medical_review" href="/d/html/6774.html" rel="external">"Cervical insufficiency", section on 'Pessary'</a>.)</p><p class="headingAnchor" id="H2106071623"><span class="h2">Antepartum fetal surveillance</span><span class="headingEndMark"> — </span>After resolution of an episode of suspected PTL, we do not perform antenatal fetal assessment (nonstress tests, biophysical profile) or serial ultrasound examinations for fetal growth assessment unless a standard medical or obstetric indication exists for these tests. PTL alone is not an indication for antepartum fetal surveillance since the risk of fetal demise is not increased in this setting. (See  <a class="medical medical_review" href="/d/html/457.html" rel="external">"Overview of antepartum fetal assessment"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Fetal fibronectin testing</span><span class="headingEndMark"> — </span>We do not use fetal fibronectin (fFN) testing to monitor asymptomatic patients who are clinically stable after an episode of acute PTL, whether or not they have had a previous fFN test. There are no studies on the use of fFN testing after an episode of PTL to further stratify preterm birth risk status and guide management. (See  <a class="medical medical_review" href="/d/html/6798.html" rel="external">"Preterm labor: Clinical findings, diagnostic evaluation, and initial treatment", section on 'Fetal fibronectin for selected patients'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Home uterine activity monitoring</span><span class="headingEndMark"> — </span>We agree with the American College of Obstetricians and Gynecologists and other expert organizations that recommend not using home uterine activity monitors to monitor patients at increased risk for PTL or recurrent PTL [<a href="#rid47">47,48</a>]. In a meta-analysis of trials of standard care "with" versus "without" home uterine activity monitoring, the intervention had no significant impact on maternal and perinatal outcomes such as perinatal mortality (RR 1.22, 95% CI 0.86-1.72, two trials, 2589 newborns) or preterm birth (average RR 0.85, CI 0.72-1.01, eight trials, 4834 participants) [<a href="#rid49">49</a>].</p><p class="headingAnchor" id="H1477267438"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/114351.html" rel="external">"Society guideline links: Preterm labor and birth"</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/6726.html" rel="external">"Patient education: Preterm labor (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antenatal corticosteroids</strong> – Patients at 23+0 to 33+6 weeks of gestation anticipated to be at increased risk for preterm birth in the next seven days should receive an initial course of antenatal corticosteroids.</p><p></p><p class="bulletIndent1">Administration of an initial course at 34+0 to 36+6 weeks is controversial; however, there is consensus that tocolysis should not be used to delay delivery for completion of a course of steroids at this gestational age.</p><p></p><p class="bulletIndent1">The indications for rescue/salvage/booster therapy are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/6796.html" rel="external">"Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Supplemental </strong><a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">progesterone</a> – For patients with a short cervix who were receiving vaginal progesterone for prevention of preterm birth, we continue their same progesterone regimen after resolution of an episode of suspected preterm labor (PTL). (See <a class="local">'Continuation of progesterone supplementation'</a> above.)</p><p></p><p class="bulletIndent1">We suggest not newly initiating <a class="drug drug_general" data-topicid="9817" href="/d/drug information/9817.html" rel="external">progesterone</a> therapy as an adjunct to tocolysis or as part of maintenance therapy after a resolved episode of PTL (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Treatment does not appear to be effective in this setting. (See  <a class="medical medical_review" href="/d/html/16560.html" rel="external">"Progesterone supplementation to reduce the risk of spontaneous preterm labor and birth", section on 'Maintenance therapy after threatened preterm labor'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Duration of hospitalization</strong> – Many patients who are stable after an episode of PTL can be managed as outpatients, as long as tests of fetal well-being are reassuring and no additional obstetric/medical complications are present that warrant hospitalization. For patients with advanced cervical dilation/effacement and/or a history of rapid labor, the travel time to a hospital with appropriate levels of obstetric and neonatal care services needs to be considered. (See <a class="local">'Duration of hospitalization'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outpatient follow-up</strong> – We schedule an office visit or telephone/telemedicine contact one week after the patient leaves the hospital and usually weekly thereafter to check for symptoms of recurrent PTL and asymptomatic cervical dilation/effacement. We do not perform antenatal fetal surveillance testing unless a standard indication exists for these tests. PTL alone is not an indication for antepartum fetal surveillance since the risk of fetal demise is not increased. (See <a class="local">'Outpatient follow-up'</a> above and <a class="local">'Antepartum fetal surveillance'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Activity</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We do not advise bed rest for patients with a recent episode of PTL given the lack of evidence of efficacy for prolonging gestation or reducing preterm birth and the known significant risks of prolonged immobility. They may continue typical activities of daily living.</p><p></p><p class="bulletIndent2">We agree with the general consensus that patients at high risk for preterm birth should limit recreational exercise and avoid returning to work if their work involves working more than 40 hours per week, night shifts, prolonged standing, or heavy physical work (eg, lifting ≥20 pounds), as this activity level has been variably associated with PTL and preterm birth. (See <a class="local">'Activities of daily life'</a> above and <a class="local">'Exercise'</a> above and <a class="local">'Work'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We advise patients with a resolved episode of PTL that they should consider avoiding sexual activity if they experience an increased frequency or intensity of contractions after sexual intercourse. (See <a class="local">'Sexual intercourse'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Travel</strong> – It is unlikely that travel significantly increases the risk of PTL or preterm birth; however, patients who wish to travel need to consider the risk of pregnancy complications away from their usual source of medical care, the availability of medical resources, and their medical insurance coverage at their destination. (See <a class="local">'Travel'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ineffective and unproven interventions</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Maintenance tocolysis, antibiotic prophylaxis, home uterine monitoring, and fibronectin testing do not improve outcomes after an episode of arrested PTL. (See <a class="local">'Ineffective and unproven interventions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients with a short cervix after an episode of PTL, neither a benefit nor serious harm from use of a cervical pessary has been established. We suggest only utilizing pessaries in this setting in the context of a clinical trial. (See <a class="local">'Cervical pessary'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">How HY, Khoury JC, Sibai BM. Cervical dilatation on presentation for preterm labor and subsequent preterm birth. Am J Perinatol 2009; 26:1.</a></li><li><a class="nounderline abstract_t">Di Tommaso M, Seravalli V, Vellucci F, et al. Relationship between cervical dilation and time to delivery in women with preterm labor. J Res Med Sci 2015; 20:925.</a></li><li><a class="nounderline abstract_t">Yost NP, Bloom SL, McIntire DD, Leveno KJ. Hospitalization for women with arrested preterm labor: a randomized trial. Obstet Gynecol 2005; 106:14.</a></li><li><a class="nounderline abstract_t">Goldenberg RL. Arrested preterm labor: do the data support home or hospital care? Obstet Gynecol 2005; 106:3.</a></li><li><a class="nounderline abstract_t">Levin HI, Sciscione A, Ananth CV, et al. Activity restriction and risk of preterm delivery. J Matern Fetal Neonatal Med 2018; 31:2136.</a></li><li><a class="nounderline abstract_t">Saccone G, Della Corte L, Cuomo L, et al. Activity restriction for women with arrested preterm labor: a randomized controlled trial. Am J Obstet Gynecol MFM 2023; 5:100954.</a></li><li><a class="nounderline abstract_t">Sosa CG, Althabe F, Belizán JM, Bergel E. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev 2015; :CD003581.</a></li><li><a class="nounderline abstract_t">Crowther CA, Han S. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev 2010; :CD000110.</a></li><li><a class="nounderline abstract_t">Goldenberg RL, Cliver SP, Bronstein J, et al. Bed rest in pregnancy. Obstet Gynecol 1994; 84:131.</a></li><li><a class="nounderline abstract_t">Allen C, Glasziou P, Del Mar C. Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet 1999; 354:1229.</a></li><li><a class="nounderline abstract_t">Kovacevich GJ, Gaich SA, Lavin JP, et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am J Obstet Gynecol 2000; 182:1089.</a></li><li><a class="nounderline abstract_t">Maloni JA, Schneider BS. Inactivity: symptoms associated with gastrocnemius muscle disuse during pregnancy. AACN Clin Issues 2002; 13:248.</a></li><li><a class="nounderline abstract_t">Maloni JA, Kane JH, Suen LJ, Wang KK. Dysphoria among high-risk pregnant hospitalized women on bed rest: a longitudinal study. Nurs Res 2002; 51:92.</a></li><li><a class="nounderline abstract_t">Maloni JA, Alexander GR, Schluchter MD, et al. Antepartum bed rest: maternal weight change and infant birth weight. Biol Res Nurs 2004; 5:177.</a></li><li><a class="nounderline abstract_t">Maloni JA, Park S. Postpartum symptoms after antepartum bed rest. J Obstet Gynecol Neonatal Nurs 2005; 34:163.</a></li><li><a class="nounderline abstract_t">Promislow JH, Hertz-Picciotto I, Schramm M, et al. Bed rest and other determinants of bone loss during pregnancy. Am J Obstet Gynecol 2004; 191:1077.</a></li><li><a class="nounderline abstract_t">ACOG Committee Opinion No. 650: Physical Activity and Exercise During Pregnancy and the Postpartum Period. Obstet Gynecol 2015; 126:e135. Reaffirmed 2019.</a></li><li><a class="nounderline abstract_t">Mocevic E, Svendsen SW, Jørgensen KT, et al. Occupational lifting, fetal death and preterm birth: findings from the Danish National Birth Cohort using a job exposure matrix. PLoS One 2014; 9:e90550.</a></li><li><a class="nounderline abstract_t">Mozurkewich EL, Luke B, Avni M, Wolf FM. Working conditions and adverse pregnancy outcome: a meta-analysis. Obstet Gynecol 2000; 95:623.</a></li><li><a class="nounderline abstract_t">McCulloch J. Health risks associated with prolonged standing. Work 2002; 19:201.</a></li><li><a class="nounderline abstract_t">Luke B, Mamelle N, Keith L, et al. The association between occupational factors and preterm birth: a United States nurses' study. Research Committee of the Association of Women's Health, Obstetric, and Neonatal Nurses. Am J Obstet Gynecol 1995; 173:849.</a></li><li><a class="nounderline abstract_t">Bonzini M, Coggon D, Palmer KT. Risk of prematurity, low birthweight and pre-eclampsia in relation to working hours and physical activities: a systematic review. Occup Environ Med 2007; 64:228.</a></li><li><a class="nounderline abstract_t">Goodlin RC, Schmidt W, Creevy DC. Uterine tension and fetal heart rate during maternal orgasm. Obstet Gynecol 1972; 39:125.</a></li><li><a class="nounderline abstract_t">Sahmay S, Atasu T, Karacan I. The effect of intrauterine insemination on uterine activity. Int J Fertil 1990; 35:310.</a></li><li><a class="nounderline abstract_t">Sayle AE, Savitz DA, Thorp JM Jr, et al. Sexual activity during late pregnancy and risk of preterm delivery. Obstet Gynecol 2001; 97:283.</a></li><li><a class="nounderline abstract_t">Hernández-Díaz S, Boeke CE, Romans AT, et al. Triggers of spontaneous preterm delivery--why today? Paediatr Perinat Epidemiol 2014; 28:79.</a></li><li><a class="nounderline abstract_t">Magann EF, Chauhan SP, Dahlke JD, et al. Air travel and pregnancy outcomes: a review of pregnancy regulations and outcomes for passengers, flight attendants, and aviators. Obstet Gynecol Surv 2010; 65:396.</a></li><li><a class="nounderline abstract_t">Akl N, Coghlan EA, Nathan EA, et al. Aeromedical transfer of women at risk of preterm delivery in remote and rural Western Australia: why are there no births in flight? Aust N Z J Obstet Gynaecol 2012; 52:327.</a></li><li><a class="nounderline abstract_t">Fry MJ, Cartwright DW, Huang RC, Davies MW. Preterm birth a long distance from home and its significant social and financial stress. Aust N Z J Obstet Gynaecol 2003; 43:317.</a></li><li><a class="nounderline abstract_t">Easa D, Pelke S, Loo SW, et al. Unexpected preterm delivery in tourists: implications for long-distance travel during pregnancy. J Perinatol 1994; 14:264.</a></li><li><a class="nounderline abstract_t">van Vliet E, Dijkema GH, Schuit E, et al. Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta-analysis. BJOG 2016; 123:1753.</a></li><li><a class="nounderline abstract_t">Dodd JM, Crowther CA, Dare MR, Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database Syst Rev 2006; :CD003927.</a></li><li><a class="nounderline abstract_t">Chawanpaiboon S, Laopaiboon M, Lumbiganon P, et al. Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes. Cochrane Database Syst Rev 2014; :CD010800.</a></li><li><a class="nounderline abstract_t">Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev 2013; :CD000940.</a></li><li class="breakAll">Terbutaline: Label Change - Warnings Against Use for Treatment of Preterm Labor http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm243843.htm (Accessed on February 17, 2011).</li><li class="breakAll">Gaudet L, Singh K, Weeks L, et al. Terbutaline Pump for the Prevention of Preterm Birth. Comparative Effectiveness Review No. 35. (Prepared by the University of Ottawa Evidence-based Practice Center under Contract No. HHSA290-2007-10059-I.) AHRQ Publication No. 11-EHC068-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2011. Available at:  www.effectivehealthcare.ahrq.gov/reports/final.cfm.</li><li><a class="nounderline abstract_t">Kaplan W, Haymond MW, McKay S, Karaviti LP. Osteopenic effects of MgSO4 in multiple pregnancies. J Pediatr Endocrinol Metab 2006; 19:1225.</a></li><li><a class="nounderline abstract_t">Valenzuela GJ, Sanchez-Ramos L, Romero R, et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 2000; 182:1184.</a></li><li><a class="nounderline abstract_t">Papatsonis DN, Flenady V, Liley HG. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour. Cochrane Database Syst Rev 2013; :CD005938.</a></li><li><a class="nounderline abstract_t">Simcox R, Sin WT, Seed PT, et al. Prophylactic antibiotics for the prevention of preterm birth in women at risk: a meta-analysis. Aust N Z J Obstet Gynaecol 2007; 47:368.</a></li><li><a class="nounderline abstract_t">van den Broek NR, White SA, Goodall M, et al. The APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysis. PLoS Med 2009; 6:e1000191.</a></li><li><a class="nounderline abstract_t">Breuking SH, De Ruigh AA, Hermans FJR, et al. Progestogen maintenance therapy for prolongation of pregnancy after an episode of preterm labour: A systematic review and meta-analysis. BJOG 2023; 130:1306.</a></li><li><a class="nounderline abstract_t">Pratcorona L, Goya M, Merced C, et al. Cervical pessary to reduce preterm birth &lt;34 weeks of gestation after an episode of preterm labor and a short cervix: a randomized controlled trial. Am J Obstet Gynecol 2018; 219:99.e1.</a></li><li><a class="nounderline abstract_t">Hermans FJR, Schuit E, Bekker MN, et al. Cervical Pessary After Arrested Preterm Labor: A Randomized Controlled Trial. Obstet Gynecol 2018; 132:741.</a></li><li><a class="nounderline abstract_t">Wetta LA, Biggio JR Jr. Cervical pessary use and preterm birth. Clin Obstet Gynecol 2014; 57:607.</a></li><li><a class="nounderline abstract_t">Dugoff L, Berghella V, Sehdev H, et al. Prevention of preterm birth with pessary in singletons (PoPPS): randomized controlled trial. Ultrasound Obstet Gynecol 2018; 51:573.</a></li><li class="breakAll">Agency for Healthcare Research and Quality. Management of preterm labor. Evidence report /Technology Assessment #18. Rockville, Maryland. 2000.</li><li><a class="nounderline abstract_t">ACOG Committee on Practice Bulletins--Obstetrics. ACOG practice bulletin. Management of preterm labor. Number 43, May 2003. Int J Gynaecol Obstet 2003; 82:127.</a></li><li><a class="nounderline abstract_t">Urquhart C, Currell R, Harlow F, Callow L. Home uterine monitoring for detecting preterm labour. Cochrane Database Syst Rev 2017; 2:CD006172.</a></li></ol></div><div id="topicVersionRevision">Topic 6795 Version 46.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19021099" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Cervical dilatation on presentation for preterm labor and subsequent preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26929755" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Relationship between cervical dilation and time to delivery in women with preterm labor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15994611" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Hospitalization for women with arrested preterm labor: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15994609" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Arrested preterm labor: do the data support home or hospital care?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28573877" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Activity restriction and risk of preterm delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37080296" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Activity restriction for women with arrested preterm labor: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25821121" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Bed rest in singleton pregnancies for preventing preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20614420" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Hospitalisation and bed rest for multiple pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8008308" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Bed rest in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10520630" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Bed rest: a potentially harmful treatment needing more careful evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10819836" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12011597" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Inactivity: symptoms associated with gastrocnemius muscle disuse during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11984379" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Dysphoria among high-risk pregnant hospitalized women on bed rest: a longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14737918" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Antepartum bed rest: maternal weight change and infant birth weight.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15781593" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Postpartum symptoms after antepartum bed rest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15507924" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Bed rest and other determinants of bone loss during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26595585" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : ACOG Committee Opinion No. 650: Physical Activity and Exercise During Pregnancy and the Postpartum Period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24614129" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Occupational lifting, fetal death and preterm birth: findings from the Danish National Birth Cohort using a job exposure matrix.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10725502" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Working conditions and adverse pregnancy outcome: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12454452" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Health risks associated with prolonged standing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7573257" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The association between occupational factors and preterm birth: a United States nurses' study. Research Committee of the Association of Women's Health, Obstetric, and Neonatal Nurses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17095552" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Risk of prematurity, low birthweight and pre-eclampsia in relation to working hours and physical activities: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5008272" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Uterine tension and fetal heart rate during maternal orgasm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1980668" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The effect of intrauterine insemination on uterine activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11165596" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Sexual activity during late pregnancy and risk of preterm delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24384058" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Triggers of spontaneous preterm delivery--why today?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20633306" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Air travel and pregnancy outcomes: a review of pregnancy regulations and outcomes for passengers, flight attendants, and aviators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22494047" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Aeromedical transfer of women at risk of preterm delivery in remote and rural Western Australia: why are there no births in flight?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14714719" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Preterm birth a long distance from home and its significant social and financial stress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7965220" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Unexpected preterm delivery in tourists: implications for long-distance travel during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27550838" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16437467" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Oral betamimetics for maintenance therapy after threatened preterm labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24659357" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23728634" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23728634" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23728634" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17172083" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Osteopenic effects of MgSO4 in multiple pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10819856" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24122673" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17877593" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Prophylactic antibiotics for the prevention of preterm birth in women at risk: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19956761" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37077041" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Progestogen maintenance therapy for prolongation of pregnancy after an episode of preterm labour: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29704487" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Cervical pessary to reduce preterm birth&lt;34 weeks of gestation after an episode of preterm labor and a short cervix: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30095769" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Cervical Pessary After Arrested Preterm Labor: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24918776" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Cervical pessary use and preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28940481" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Prevention of preterm birth with pessary in singletons (PoPPS): randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28940481" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prevention of preterm birth with pessary in singletons (PoPPS): randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12834934" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : ACOG practice bulletin. Management of preterm labor. Number 43, May 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28205207" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Home uterine monitoring for detecting preterm labour.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
